Literature DB >> 16513374

Histone H1 inhibits the proliferation of MCF 7 and MDA MB 231 human breast cancer cells.

G Vani1, A J Vanisree, C S Shyamaladevi.   

Abstract

Purified histone H1 exerts extracellular functions suggesting novel histone functions. The cytotoxic effects of histone H1 have lead to its choice as a pharmacological tool in breast cancer. Hence the present study was aimed at investigating the effect of exogenous histone H1 on the proliferation of estrogen receptor positive (MCF 7) and estrogen receptor negative (MDA MB 231) human breast cancer cells. Cells were incubated with various concentrations of histone H1 and antiproliferative activity was assessed by MTT assay. Proliferation of breast cancer cells was assessed from the activity of ornithine decarboxylase (ODC) using [(14)C] labeled ornithine. Histone H1-mediated cellular effects, such as anchorage dependent growth and apoptosis, were assessed by colony formation assay, fluorescence microscopy after acridine orange/propidium iodide staining and DNA fragmentation analysis. Histone H1 was significantly cytotoxic as it inhibited colony formation, ODC activity and induced apoptosis in both estrogen receptor positive and estrogen receptor negative cells. These results suggest that histone H1-induced antiproliferative effects on human breast cancer cells could possibly involve inhibition of ODC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16513374     DOI: 10.1016/j.cellbi.2005.12.004

Source DB:  PubMed          Journal:  Cell Biol Int        ISSN: 1065-6995            Impact factor:   3.612


  2 in total

1.  Moesin is a biomarker for the assessment of genotoxic carcinogens in mouse lymphoma.

Authors:  Yoen Jung Lee; In-Kwon Choi; Yhun Yhong Sheen; Sue Nie Park; Ho Jeong Kwon
Journal:  Mol Cells       Date:  2012-01-26       Impact factor: 5.034

2.  Characteristics of cross-hybridization and cross-alignment of expression in pseudo-xenograft samples by RNA-Seq and microarrays.

Authors:  Camilo Valdes; Pearl Seo; Nicholas Tsinoremas; Jennifer Clarke
Journal:  J Clin Bioinforma       Date:  2013-04-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.